DE60233801D1 - Verfahren zur behandlung von gelenkentzündung, schmerzen und mobilitätsverlust - Google Patents

Verfahren zur behandlung von gelenkentzündung, schmerzen und mobilitätsverlust

Info

Publication number
DE60233801D1
DE60233801D1 DE60233801T DE60233801T DE60233801D1 DE 60233801 D1 DE60233801 D1 DE 60233801D1 DE 60233801 T DE60233801 T DE 60233801T DE 60233801 T DE60233801 T DE 60233801T DE 60233801 D1 DE60233801 D1 DE 60233801D1
Authority
DE
Germany
Prior art keywords
rice bran
pain
treating joint
preferred
mobility loss
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60233801T
Other languages
English (en)
Inventor
Patricia Mcpeak
Rukmini Cheruvanky
Reddy Sastry Cherukuri
Mohammed Mazhar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NutraCea
Original Assignee
NutraCea
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NutraCea filed Critical NutraCea
Application granted granted Critical
Publication of DE60233801D1 publication Critical patent/DE60233801D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE60233801T 2001-07-23 2002-07-23 Verfahren zur behandlung von gelenkentzündung, schmerzen und mobilitätsverlust Expired - Fee Related DE60233801D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30758801P 2001-07-23 2001-07-23
US10/012,270 US6902739B2 (en) 2001-07-23 2001-11-06 Methods for treating joint inflammation, pain, and loss of mobility
PCT/US2002/023508 WO2003009741A2 (en) 2001-07-23 2002-07-23 Methods for treating joint inflammation, pain, and loss of mobility

Publications (1)

Publication Number Publication Date
DE60233801D1 true DE60233801D1 (de) 2009-11-05

Family

ID=26683357

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60233801T Expired - Fee Related DE60233801D1 (de) 2001-07-23 2002-07-23 Verfahren zur behandlung von gelenkentzündung, schmerzen und mobilitätsverlust

Country Status (9)

Country Link
US (3) US6902739B2 (de)
EP (1) EP1416966B1 (de)
JP (1) JP2005501043A (de)
AT (1) ATE443523T1 (de)
AU (1) AU2002315558B2 (de)
CA (1) CA2454658C (de)
DE (1) DE60233801D1 (de)
HK (1) HK1065943A1 (de)
WO (1) WO2003009741A2 (de)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6902739B2 (en) * 2001-07-23 2005-06-07 Nutracea Methods for treating joint inflammation, pain, and loss of mobility
EP1496880A4 (de) * 2002-04-24 2007-12-12 Res Dev Foundation SYNERGISTISCHE WIRKUNGEN VON NUKLEÄREN TRANSKRIPTIONSFAKTOR NF-kB HEMMERN UND ANTINEOPLASTISCHE MITTEL
WO2004000229A2 (en) * 2002-06-24 2003-12-31 Research Development Foundation Treatment of human multiple myeloma by curcumin
US20040029774A1 (en) * 2002-08-06 2004-02-12 Aly Gamay Composition and methods for the treatment of musculoskeletal disorders and collagen and elastin deficiencies
US20040086581A1 (en) * 2002-11-06 2004-05-06 Jones Edwin B. Bio-energetic joint and arthritis pain formula
US20040102421A1 (en) * 2002-11-21 2004-05-27 Children's Hospital Research Center At Oakland Tocopherol and tocotrienol anti-inflammatory medicaments
US6887497B2 (en) * 2002-12-19 2005-05-03 Vitacost.Com, Inc. Composition for the treatment and prevention of osteoarthritis, rheumatoid arthritis and improved joint function
GB0307989D0 (en) * 2003-04-07 2003-05-14 Mcewen Lab Ltd Therapeutic composition
JP4596751B2 (ja) * 2003-06-11 2010-12-15 帝國製薬株式会社 消炎鎮痛貼付剤
EP1502594A1 (de) * 2003-07-31 2005-02-02 Pynogin GmbH Eine Zusammensetzung zur Minimierung des Thromboserisikos enthaltend eine Mischung von Proanthocyanidine und Sesquiterpene
CA2536380A1 (en) * 2003-08-26 2005-02-26 Research Development Foundation Osteoclastogenesis inhibitors and uses thereof
WO2005032478A2 (en) * 2003-10-01 2005-04-14 Yasoo Health, Inc. Treatment for diabetic microvascular and macrovascular complications
WO2005110122A1 (en) * 2004-05-18 2005-11-24 Dsm Ip Assets B.V. USE OF β-CRYPTOXANTHIN
CA2479632C (en) * 2004-08-31 2011-07-26 Tassos Anastassiades Method for increasing the bone mineral density of a mammal using n-acylated glucosamines
US20060093592A1 (en) * 2004-10-04 2006-05-04 Nutracea Synbiotics
WO2006058248A2 (en) * 2004-11-24 2006-06-01 Hill's Pet Nutrition, Inc. Methods for increasing the immune response in an animal
US20090176864A1 (en) * 2004-11-24 2009-07-09 Hill's Pet Nutrition, Inc. Methods For Improving Hepatic and Immune Function In An Animal
RU2432159C2 (ru) * 2004-11-24 2011-10-27 Хилл'С Пет Ньютришн, Инк. Способы для улучшения обезвреживания печенью ксенобиотических веществ у животных
AU2012202194B2 (en) * 2004-12-24 2014-04-24 Dolphst Pty Ltd. Formulations and treatments for well-being
EP1841505A4 (de) * 2004-12-24 2010-01-27 Dolphst Pty Ltd Formel-ionen und behandlungen für das wohlbefinden
TWI354559B (en) * 2004-12-27 2011-12-21 Yaizu Suisankagaku Ind Co Ltd Oral disintegrative n-acetylglucosamine tablet and
US8252742B2 (en) 2004-12-30 2012-08-28 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
AU2005322887B2 (en) * 2004-12-30 2010-03-11 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
JP4824933B2 (ja) * 2005-01-14 2011-11-30 共栄化学工業株式会社 化粧料
JP2008531569A (ja) * 2005-02-22 2008-08-14 メリアル リミテッド ガンマ−トコフェロールの投与によりｃｏｘ−２介在障害を選択的に治療する方法
US8128967B2 (en) * 2005-03-08 2012-03-06 Mitsui Norin Co., Ltd. Polyphenol coxib combinations and methods
JP2008542300A (ja) * 2005-05-24 2008-11-27 ウェルルゲン インコーポレーテッド 炎症と関連した状態を予防及び治療するための組成物及び方法
WO2007033180A1 (en) 2005-09-12 2007-03-22 Abela Pharmaceuticals, Inc. Materials for facilitating administration of dimethyl sulfoxide (dmso) and related compounds
US8480797B2 (en) 2005-09-12 2013-07-09 Abela Pharmaceuticals, Inc. Activated carbon systems for facilitating use of dimethyl sulfoxide (DMSO) by removal of same, related compounds, or associated odors
AU2006291134C1 (en) 2005-09-12 2013-08-15 Abela Pharmaceuticals, Inc. Systems for removing dimethyl sulfoxide (DMSO) or related compounds, or odors associated with same
US9427419B2 (en) 2005-09-12 2016-08-30 Abela Pharmaceuticals, Inc. Compositions comprising dimethyl sulfoxide (DMSO)
US20080038385A1 (en) * 2006-03-13 2008-02-14 Nutracea Therapeutic uses of an anti-cancer composition derived from rice bran
US20070212470A1 (en) * 2006-03-13 2007-09-13 Nutracea Therapeutic uses of an anti-cancer composition derived from rice bran
US20070231449A1 (en) * 2006-03-30 2007-10-04 Nutracea Non-starchy rice bran polysaccharides
JPWO2008013219A1 (ja) * 2006-07-28 2009-12-17 ユニチカ株式会社 クリプトキサンチンの高吸収性経口投与組成物
US20080045475A1 (en) * 2006-08-20 2008-02-21 Phillip Edward Littmann Elemental cellular therapy is a genetic, cellular and disease-modifying therapy which enhances the systemic conduct of genetic and cellular transmethylation activity resulting in enhancement of concerted genetic and cellular metabolic, physiologic and homeostatic processes
US7754256B2 (en) * 2007-03-07 2010-07-13 Stan Dennison Nutritional composition
US20090155439A1 (en) * 2007-12-14 2009-06-18 Leo Gingras Mechanical extrusion process for stabilizing cereal and oil seed bran and germ components
US20090162513A1 (en) * 2007-12-20 2009-06-25 Leo Gingras Rice hull composition
WO2009082475A1 (en) * 2007-12-21 2009-07-02 Nutracea Production of pasta using rice bran and rice floor
US20090175967A1 (en) * 2008-01-04 2009-07-09 Nutracea Methods for treatment of intestinal carcinogenesis with rice bran
WO2009117584A2 (en) * 2008-03-20 2009-09-24 Lynn Chambers Anti-inflammatory drug delivery system
US20100015258A1 (en) * 2008-05-18 2010-01-21 Alberte Randall S Rice Bran Extracts and Methods of Use Thereof
SI2296494T2 (sl) * 2008-06-16 2022-08-31 N.V. Nutricia Mlečna formulacija z maščobnim gradientom za dojenčka
US20100015306A1 (en) * 2008-07-15 2010-01-21 Pepsico, Inc. Method for Preparing a Low Viscosity Whole Grain Flour Slurry
EP2554056B1 (de) 2008-09-02 2019-12-04 N.V. Nutricia NÄHRSTOFFZUSAMMENSETZUNGEN MIT GROßER FETTKÜGELCHENGRÖßE UND MIT EINER BESCHICHTUNG AUS PHOSPHOLIPIDEN
BRPI0921494A2 (pt) 2008-11-03 2018-10-30 Prad Reasearch And Development Ltd método de planejamento de uma operação de amostragem para uma formação subterrãnea, método de contolar uma operação de amostragem de formação subterrânea, método de controlar uma operação de perfuração para uma formação subterrãnea, e método de realizar uma amostragem durante a operação de perfuração.
WO2010068086A1 (en) 2008-12-11 2010-06-17 N.V. Nutricia Nutritional compositions with large lipid globule size
US20100178400A1 (en) * 2009-01-13 2010-07-15 Pepsico, Inc. Method of Preparing a Whole Grain Beverage
EP2493314B1 (de) 2009-10-30 2020-04-08 Abela Pharmaceuticals, Inc. Dimethylsulfoxid (dmso)- und methylsulfonylmethan (msm)-formulierungen zur behandlung von osteoarthritis
BR112012015959A2 (pt) 2009-12-29 2019-09-24 Hills Pet Nutrition Inc composições incluindo gengibre para a melhora ou prevenção de condições inflamatórias
WO2011115476A1 (en) 2010-03-17 2011-09-22 N.V. Nutricia Infant nutrition for improving fatty acid composition of brain membranes later in life
US8945642B2 (en) 2010-09-15 2015-02-03 Ike E. Lynch Nutritionally enhanced isolate from stabilized rice bran and method of production
US9192180B2 (en) 2010-09-15 2015-11-24 Paul Raymond Reising Nutritionally enhanced fraction from rice bran and method of lowering insulin resistance using same
US20140271594A1 (en) * 2013-03-16 2014-09-18 Stephen T. Sinatra Equine supplement
WO2013108263A1 (en) 2012-01-18 2013-07-25 Zota Health Care Ltd Pharmaceutical formulation to reduce inflammation of bones and joint friction with improved cartilage quality
US20150056176A1 (en) * 2012-01-18 2015-02-26 Stanley N. Jankowitz Anti-inflammatory composition
CN104427982B (zh) * 2012-04-02 2017-05-17 鹰制药私人有限公司 治疗炎性和免疫障碍的组合物
GB201302755D0 (en) * 2013-02-15 2013-04-03 Mars Inc Horse supplement
WO2015065193A1 (en) 2013-11-01 2015-05-07 N.V. Nutricia Lipid composition for improving body composition during catch-up growth
FR3019742A1 (fr) * 2014-04-09 2015-10-16 Lutecie Composition pour le traitement de l'hypercholesterolemie
WO2016025202A1 (en) * 2014-08-14 2016-02-18 The Regents Of The University Of Colorado Antibody-sirna conjugates and uses therefor
ES2742522T3 (es) 2015-10-15 2020-02-14 Nutricia Nv Fórmulas para lactantes con arquitectura lipídica especial para promover el crecimiento saludable
GB2546511A (en) * 2016-01-20 2017-07-26 Dodson & Horrell Ltd Horse food supplement
RU2748025C2 (ru) 2016-12-09 2021-05-19 Н.В. Нютрисиа Питательный состав для улучшения клеточных мембран
US11090365B2 (en) 2019-08-08 2021-08-17 SVK Herbal Corporation Composition and methods for treating bone and joint disease including extract from crocodilos reptilia and herbs

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4129648A (en) * 1977-11-21 1978-12-12 Collier Harry O J Method for reducing endogenous prostaglandin synthesis
US4616039A (en) * 1979-08-30 1986-10-07 Herschler R J Methylsulfonylmethane in dietary products
JPS5659710A (en) * 1979-10-22 1981-05-23 Eisai Co Ltd Preventive and remedy for psoriasis
US4628052A (en) * 1985-05-28 1986-12-09 Peat Raymond F Pharmaceutical compositions containing dehydroepiandrosterone and other anesthetic steroids in the treatment of arthritis and other joint disabilities
JPS61286317A (ja) 1985-06-13 1986-12-16 Osaka Chem Lab 浴用剤
JPS6379834A (ja) 1986-09-25 1988-04-09 Kozo Niwa 活性酸素抑制組成物
JPH04320645A (ja) 1991-04-19 1992-11-11 Tokyo Yushi Kogyo Kk 強化米ぬか油の製法
EP0543417A1 (de) * 1991-11-22 1993-05-26 Lipogenics, Incorporated Tocotrienole und Focotrienol-ähnliche Verbindungen und Verfahren zu ihrer Verwendung
US5292537A (en) 1992-11-12 1994-03-08 Bran Tec, Inc. Method for stabilizing rice bran and rice bran products
US5545398A (en) * 1993-01-13 1996-08-13 Perricone; Nicholos V. Method and compositions for topical application to the skin of tocotrienol for prevention and/or treatment of skin damage
US5583120A (en) * 1993-08-04 1996-12-10 Patent Biopharmaceutics, Inc. Hyaluronic acid-urea pharmaceutical compositions and uses
US5595982A (en) * 1994-03-31 1997-01-21 Harlmen Inc. Equine nutritional supplement
US5656312A (en) * 1994-09-02 1997-08-12 Erasmus; Udo Dietary food supplement and method of preparing
US5552167A (en) * 1995-05-05 1996-09-03 Nabisco, Inc. Rice bran oil antioxidant
US5709855A (en) * 1995-09-22 1998-01-20 Bockow; Barry I. Compositions of spirulina algae and omega fatty acids for treatment of inflammation and pain
US5916565A (en) 1996-03-08 1999-06-29 In Clover, Inc. Product and method for treating joint disorders in vertebrates
US6248378B1 (en) * 1998-12-16 2001-06-19 Universidad De Sevilla Enhanced food products
FR2763336B1 (fr) * 1997-05-14 1999-08-06 Lvmh Rech Esters de tocopherol et leurs utilisations en cosmetique et pharmacie
WO1999010002A1 (en) 1997-08-29 1999-03-04 The Ricex Company, Inc. A method for treating diabetes, hyperglycemia and hypoglycemia
AU9209898A (en) 1997-09-02 1999-03-22 Ricex Company, Inc., The A method for treating hypercholesterolemia, hyperlipidemia, and atherosclerosis
US5985344A (en) 1997-09-02 1999-11-16 The Ricex Company Process for obtaining micronutrient enriched rice bran oil
US5972985A (en) * 1997-11-03 1999-10-26 Cytos Pharmaceuticals, Llc Histidine containing nutriceutical compositions
US5922692A (en) * 1998-03-11 1999-07-13 Marino; Richard P. Concentration of glycosaminoglycans and precursors thereto in food products
US6046179A (en) * 1998-04-17 2000-04-04 Murch; Simon Composition for and treatment of inflammatory bowel disease by colon administration of N-acetylglucosamine
US6391864B1 (en) 1998-08-19 2002-05-21 Joint Juice, Inc. Food supplement containing a cartilage supplement
US6217914B1 (en) 1999-03-19 2001-04-17 Bioderm, Inc. Ascorbic acid composition and method for treatment of aging or damaged skin
US6428817B1 (en) * 1999-07-06 2002-08-06 Peter Donald Collin Companion animal therapeutic treat
US6245377B1 (en) 1999-08-04 2001-06-12 Mars Incorporated Method of stabilization of rice bran by acid treatment and composition of the same
JP4585070B2 (ja) 1999-12-08 2010-11-24 丸善製薬株式会社 サイクリックａｍｐホスホジエステラーゼ阻害剤および抗アレルギー・抗炎症剤
US20020132780A1 (en) * 2001-01-12 2002-09-19 Heisey Matthew Thomas Low carbohydrate compositions, kits thereof, and methods of use
US6902739B2 (en) * 2001-07-23 2005-06-07 Nutracea Methods for treating joint inflammation, pain, and loss of mobility

Also Published As

Publication number Publication date
EP1416966B1 (de) 2009-09-23
EP1416966A4 (de) 2005-03-02
US20050158406A1 (en) 2005-07-21
CA2454658C (en) 2011-10-25
US20050214392A1 (en) 2005-09-29
ATE443523T1 (de) 2009-10-15
US6902739B2 (en) 2005-06-07
HK1065943A1 (en) 2005-03-11
JP2005501043A (ja) 2005-01-13
WO2003009741A3 (en) 2003-07-24
WO2003009741A2 (en) 2003-02-06
EP1416966A2 (de) 2004-05-12
CA2454658A1 (en) 2003-02-06
US20030118672A1 (en) 2003-06-26
AU2002315558B2 (en) 2007-07-05

Similar Documents

Publication Publication Date Title
DE60233801D1 (de) Verfahren zur behandlung von gelenkentzündung, schmerzen und mobilitätsverlust
WO2003094836A3 (en) Methods and products for enhancing immune responses using imidazoquinoline compounds
ATE556706T1 (de) Fettalkohol-arzneimittel-konjugate
WO2002076402A3 (en) Fatty amine drug conjugates
WO2004087203A3 (en) Immunostimulatory nucleic acid oil-in-water formulations for topical application
MXPA05006940A (es) Formulaciones terapeuticas para el tratamiento de enfermedades relacionadas con beta - amiloide.
WO2003096990A3 (en) Protein cages for the delivery of medical imaging and therapy
WO2003030934A3 (en) Cpg formulations and related methods
NO20050807L (no) Farmasoytiske sammensetninger som innbefatter dekstrometorfan og kinidin for behandling av neurologiske forstyrrelser
AU2003220970A1 (en) Diamino-pyrimidines and their use as angiogenesis inhibitors
WO2003099771A3 (en) Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
WO1998010767A3 (en) Use of quinazoline derivatives for the manufacture of a medicament in the treatment of hyperproliferative skin disorders
DE69909818D1 (de) Pyrazolopyimidinon-derivate zur behandlung von impotenz
BRPI0415858A (pt) compostos de medicamentos terapêuticos modificados por tocoferol
NO20034056D0 (no) Proliferative sykdommer
WO2005055944A3 (en) Oligosaccharide compositions and use thereof in the treatment of infection
DE60229971D1 (de) Zubereitungen zur reizhemmenden rosacea-behandlung
WO2002040702A3 (en) Methods for the treatment of cancer and other diseases and methods of developing the same
HK1067073A1 (en) Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
PT1057828E (pt) Suspensoes de trovafloxacina para administracao oral
ATE318610T1 (de) Orale zusammensetzungen zur behandlung von kopfhauterkrankungen
SE9603725D0 (sv) New teatment
WO2004073615A8 (en) Deazaflavin compounds and methods of use thereof
ATE267816T1 (de) Tan-1057 derivate
DK1343472T3 (da) Thixotropisk næsespray

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee